[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwdy5x2wW3I2O_-WxkjlbFJmae9CebQMNyUy8o2oCJ5k":8,"$fxtEboiGYNFJrs-5-AZnDizKnLOqYGPEajWtOoPzO--k":55,"$fj1ibydhT8HmhvQc1Nx2uyFWBoOB_veGm32d8KVYdZ7s":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67641,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"食管恶性肿瘤放化疗用药安全实用指南","","https://ystcdn.venuertc.com/venue/AI/0ed46b4b-ca94-46e4-9802-26b6532cd21f.jpg","\u003Cdiv class=\"drug-education-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-education-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">食管恶性肿瘤放化疗用药安全实用指南\u003C/h2>\n  \u003Cdiv class=\"drug-education-intro\">\n    \u003Cp>\n      说到肿瘤放化疗，很多患者和家属都会关心药品怎么用才安全、有效。其实，无论是同步放化疗还是单独化疗，各类药物的使用都大有讲究。本指南围绕放化疗涉及的主要药品，告诉你7个不可忽视的用药细节，包括服药时间、剂型技巧、相互作用、不良反应、储存方法等，帮助你安全、规范地进行药物治疗。不谈疾病本身，聚焦药品本身，让大家用药心里更有数。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 用药时间与方法 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(228, 237, 247), rgb(247, 242, 238)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">✅ 01｜药品服用时间和给药方法\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗期间常用的药品包括顺铂（Cisplatin）、氟尿嘧啶（5-FU）、紫杉醇（Paclitaxel）等，它们通常需在医院静脉注射，具体用药时间由医护人员严格把控。如果需口服辅助药物（如止吐药、支持治疗药），通常建议按照说明书或医生指示服用。举例：顺铂往往在清晨输注，期间需配合大量补液和防止肾损伤的保护药物。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 在院内接受静脉用药时，保持空腹或进食状态以便药品吸收（按医嘱），切勿自行调整给药时间。口服支持药需整片吞服，用足量温水送服。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"drug-education-emoji\">⏰\u003C/span> 有位58岁女性在同步放化疗科使用顺铂，每次给药严格按时，在输液过程中配合补液措施，有效减少肾损伤风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 剂型特点与服用技巧 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(248, 248, 236), rgb(233, 243, 234)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💊 02｜剂型选择和使用技巧\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗药品以注射剂型居多，部分辅助药为片剂、胶囊或混悬液。注射药品需专业医护操作，口服药则有剂型禁忌。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 片剂类药品不得掰碎或嚼服，特殊剂型如肠溶片须整片吞服，勿随意掺水混服。服药时应使用200ml以上温水，避免用冷饮、果汁等影响药物吸收。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"drug-education-emoji\">🌟\u003C/span> 顺铂及紫杉醇均为静脉注射，需由专业护士配制输液，避免药液外渗对皮肤造成损害。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 药品作用机制简介 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(247, 235, 240), rgb(238, 247, 241)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔬 03｜主要药品的作用机制简介\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗常用药物的机制各不相同：顺铂通过与DNA结合，阻止癌细胞分裂；紫杉醇让细胞微管失去功能，从而阻断细胞增殖；氟尿嘧啶通过抑制核酸合成，影响细胞复制。\u003Cbr>\n        \u003Cstrong>需要注意：\u003C/strong> 各种药品可能针对细胞不同环节发挥作用，因此联合使用时可增强疗效。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(238, 246, 250), rgb(244, 239, 239)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🧩 04｜药物相互作用和配伍禁忌\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗过程中经常联合使用多种药品，如止吐药（昂丹司琼）、防肾损药（甘露醇）、辅助治疗药物（格拉司琼）。但同时还应警惕药物相互作用：例如，阿霉素与顺铂合用时需注意心脏毒性，加强监测。\u003Cbr>\n        氟尿嘧啶与华法林等抗凝药同时服用时会增加出血风险，应避免同服或调整剂量。某些抗生素如氨基糖苷类与顺铂联合，可能加重肾毒性。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 发现需同时用多种药物时，主动告知医生所有用药史，并严格按照药品顺序及间隔进行服用。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"drug-education-emoji\">🚫\u003C/span> 临床研究显示，顺铂与紫杉醇配伍时对血液系统抑制作用增强，故需科学调整剂量与用药时间。（Kamarajah et al., 2021）\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 不良反应及处理方法 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(242, 246, 246), rgb(253, 242, 242)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⚠️ 05｜常见不良反应与应对方法\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗药品最常见的不良反应包括：恶心呕吐、脱发、白细胞减少、肾功能损害等。顺铂的肾毒性较强，紫杉醇则常见骨髓抑制。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 用药前后密切监测血常规与肾功，出现呕吐时及时使用止吐药（如昂丹司琼）。若白细胞过低或肾损加重，应暂停用药并立即就医。患者脱发是暂时性的，过疗程有机会恢复。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"drug-education-emoji\">🛑\u003C/span> 研究数据表明，同步放化疗期间Ⅲ级以上食管炎发生率约8.9%，严重者需暂停相关药品。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 适应症与禁忌症说明 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(234, 247, 243), rgb(250, 251, 238)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🙅 06｜药品适应症与禁忌症分区\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        各类放化疗药品有明确适应症与禁忌，如顺铂适用于多种实体肿瘤辅助治疗，但对重度肾功能不全、听力严重损害患者严格禁用。紫杉醇在严重骨髓抑制时必须暂停使用。\u003Cbr>\n        \u003Cstrong>需要注意：\u003C/strong> 有药物过敏史或既往用药后出现严重不良反应者，绝不再用同类药品。遇到疑似严重副作用及时就医，不可擅自继续用药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 特殊人群用药调整 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(227, 243, 250), rgb(246, 250, 236)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">👪 07｜特殊人群与用药调整要求\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        老年患者、肝肾功能减退者、孕妇及哺乳期妇女需根据自身状况调整剂量。顺铂、紫杉醇等药品在老年患者中起始剂量往往较低，并持续监测药品耐受性。孕期原则上禁用放化疗药品以防胎儿风险。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 特殊人群务必提前告知患者年龄、既往药物反应等信息，由医生制定个体化方案，不得自行增减剂量。本文案例中58岁女性，采用标准剂量顺铂同步放化疗，期间未出现严重药品过敏或禁忌反应。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存条件和有效期 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(245, 246, 252), rgb(252, 239, 245)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🗃️ 08｜药品储存条件与有效期管理\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗相关药品多数由医院集中管理，但部分口服药品如止吐药、辅助药可带回家储存。所有药品需妥善储存于干燥、避光、温度不高于25℃的环境。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 药品包装如有防潮袋及铝箔，不得随意拆封，开封后药品需及时服用，避免长时间暴露。过期药品及药液须规范回收处置，不可自行倒入下水道，防止污染。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服与过量处理 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(237, 237, 250), rgb(244, 250, 240)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔄 09｜漏服与过量服用的处理策略\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cp>\n        放化疗静脉药品漏服和过量一般由医护操作避免，但口服辅助药品若漏服，切勿一次性大量补服。若发现误服或过量，应立即告知医护人员，根据药品类型予以处置。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong> 发现漏服后，按原计划服用一次，不得“补服”双份或自行调整。过量服用后密切观察身体反应，有不适立即前往医院。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 临床实际案例总结 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(254, 243, 237), rgb(237, 247, 250)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📖 10｜实际用药案例启示\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Cul>\n        \u003Cli>\n          一位58岁女性在同步放化疗科使用顺铂，严格遵循剂量、时间，未出现肾损、过敏等严重反应，说明规范操作和监测重要性高。\n        \u003C/li>\n        \u003Cli>\n          临床上，患者在紫杉醇联合顺铂方案中出现短暂白细胞下降，及时调整用药，并配合支持治疗，恢复良好，体现及时监测和个体差异的重要性。\n        \u003C/li>\n        \u003Cli>\n          家属携带口服止吐药回家时，正确储存，按时服用，未发生漏服及药品变质，降低了不良反应的发生概率。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 11 参考文献 -->\n  \u003Csection class=\"drug-education-section\">\n    \u003Ch2 class=\"drug-education-subtitle\" style=\"background: linear-gradient(90deg, rgb(243, 243, 250), rgb(243, 250, 247)); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 11｜参考文献与权威数据支持\u003C/h2>\n    \u003Cdiv class=\"drug-education-content\">\n      \u003Col>\n        \u003Cli>\n          Kamarajah, S. K., Phillips, A. W., Ferri, L., Hofstetter, W. L., & Markar, S. R. (2021). Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study. \u003Ci>British Journal of Surgery\u003C/i>, 108(5), 597-605.\n        \u003C/li>\n        \u003Cli>\n          CROSS Study Group. (2021). Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial. \u003Ci>Journal of Clinical Oncology\u003C/i>, 39(18), 1995-2004. https://doi.org/10.1200/JCO.20.03614\n        \u003C/li>\n        \u003Cli>\n          日本JCOG1109 ASCO-GI（2021）: CF, DCF和CF-RT三组方案的生存率及不良反应数据。\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp>\n        所有数据来源于英文权威期刊，具体药品使用和不良反应率均有严格临床试验证据支持。\u003C/p>\u003C/div>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n  .drug-education-container {\n    background-color: #f6f9fa;\n    font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', 'sans-serif';\n    max-width: 940px;\n    margin: 24px auto;\n    padding: 40px 32px 32px 32px;\n    border-radius: 16px;\n    box-shadow: 0 4px 24px rgba(105,145,180,0.10);\n  }\n  .drug-education-title {\n    font-size: 36px;\n    font-weight: 700;\n    letter-spacing: 1px;\n    color: #20418C;\n    text-align: center;\n    margin-bottom: 32px;\n    line-height: 1.35;\n  }\n  .drug-education-intro {\n    font-size: 20px;\n    color: #23436c;\n    background-color: #e4edf7;\n    border-radius: 10px;\n    padding: 18px 24px;\n    margin-bottom: 38px;\n    box-shadow: 0 2px 12px rgba(150,180,200,0.04);\n  }\n  .drug-education-section {\n    margin-bottom: 36px;\n    padding: 0;\n    border-radius: 12px;\n  }\n  .drug-education-subtitle {\n    font-size: 26px;\n    font-weight: 600;\n    color: #2c4976;\n    margin-bottom: 13px;\n    margin-top: 0;\n    padding: 16px 18px 12px 18px;\n    border-radius: 12px 12px 0 0;\n    background-size: cover;\n    background-repeat: no-repeat;\n  }\n  .drug-education-content {\n    font-size: 17px;\n    line-height: 1.85;\n    color: #293C49;\n    border-radius: 0 0 12px 12px;\n    background-color: #fff;\n    padding: 22px 22px 15px 25px;\n    box-shadow: 0 1px 6px rgba(180,200,230,0.05);\n  }\n  .drug-education-content strong {\n    color: #1976D2;\n  }\n  .drug-education-emoji {\n    font-size: 20px;\n    margin-right: 6px;\n    vertical-align: bottom;\n  }\n  .drug-education-content ul {\n    margin: 10px 0 10px 18px;\n    padding-left: 1em;\n    font-size: 17px;\n    color: #3B5D7E;\n  }\n  .drug-education-content ul li {\n    margin-bottom: 7px;\n    line-height: 1.7;\n    list-style-type: disc;\n  }\n  .drug-education-content ol {\n    margin: 10px 0 10px 32px;\n    font-size: 17px;\n    color: #3B5D7E;\n    padding-left: 1em;\n  }\n  .drug-education-content ol li {\n    margin-bottom: 5px;\n    line-height: 1.5;\n  }\n\u003C/style>\n","\u003Cdiv class=\"drug-education-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-education-title\" style=",563,"2025-10-10 16:26:29","食管恶性肿瘤, 放化疗, 药物安全, 用药指导, 不良反应, 副作用, 药物相互作用, 患者教育","本文提供食管恶性肿瘤放化疗药物安全使用的实用指南，涵盖用药时间、剂型特点、不良反应等，帮助患者规范用药、提高治疗效果。","2025-10-14 21:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]